Bill Text: NY A06506 | 2023-2024 | General Assembly | Introduced

NOTE: There are more recent revisions of this legislation. Read Latest Draft

---

Bill Title: Prohibits the sale of xylazine to persons under the age of 21 and without proof of the intended use for institutional, veterinary, or scientific purposes.

Spectrum: Slight Partisan Bill (Democrat 24-8)

Status: (Engrossed) 2024-03-18 - REFERRED TO CONSUMER PROTECTION [A06506 Detail]

Download: New_York-2023-A06506-Introduced.html

---

                STATE OF NEW YORK
        ________________________________________________________________________

                                          6506

                               2023-2024 Regular Sessions

                   IN ASSEMBLY

                                     April 12, 2023
                                       ___________

        Introduced  by  M. of A. TAPIA, ZACCARO -- read once and referred to the
          Committee on Consumer Affairs and Protection

        AN ACT to amend the general business law, in relation to prohibiting the
          sale of xylazine

          The People of the State of New York, represented in Senate and  Assem-
        bly, do enact as follows:

     1    Section 1. The general business law is amended by adding a new section
     2  392-k to read as follows:
     3    §  392-k.  Sale of xylazine. 1. For purposes of this section, the term
     4  "xylazine" shall mean a pharmaceutical drug  used  for  sedation,  anes-
     5  thesia,  muscle  relaxation,  and  analgesia  in animals such as horses,
     6  cattle, and other non-human mammals.
     7    2. No person, corporation,  partnership,  limited  liability  company,
     8  firm, online platform, or any other business entity doing business with-
     9  in  this  state shall sell, offer for sale, or deliver xylazine to indi-
    10  viduals without proof of its intended use for institutional or scientif-
    11  ic purposes.
    12    3. No person, corporation,  partnership,  limited  liability  company,
    13  firm,  online  platform,  or other business entity doing business within
    14  this state shall sell, offer for sale, or deliver xylazine  to  individ-
    15  uals under the age of twenty-one.
    16    4.  Any  person,  corporation, partnership, limited liability company,
    17  firm, online platform or other business  entity  doing  business  within
    18  this  state which sells, offers for sale, or distributes xylazine, shall
    19  require and retain sales records, proof of age, and proof  of  use  from
    20  all purchasers.
    21    5.  Any  individual harmed by a violation of this section shall have a
    22  private right of action for compensatory and  actual  damages,  punitive
    23  damages, attorneys' fees and costs.
    24    § 2. This act shall take effect immediately.

         EXPLANATION--Matter in italics (underscored) is new; matter in brackets
                              [ ] is old law to be omitted.
                                                                   LBD10463-01-3